Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Cancer Drug Coverage Parity Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials regulations and coverage Cancer Drug Coverage Parity Act (H.R. 1801)Cancer Drug Coverage Parity Act (H.R. 1801)
American Taxpayer Relief Act of 2012
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2013 · second_quarter · Q2
Sickle Cell Disease/Trait Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials regulations and coverage Cancer Drug Coverage Parity Act (H.R. 1801)Cancer Drug Coverage Parity Act (H.R. 1801)
Source: Senate LDA
FY 2013 Funding for the National Institutes of Health Public Health Program Funding H.R. 933, Consolidated and Further Continuing Appropriations Act, 2013 H.R. 8, American Taxpayer Relief Act of 2012
Preserving Access to Life-Saving Medications Act of 2011
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Thrombosis Sickle Cell Disease/Trait Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act H.R. 3839, the Drug Shortage Prevention Act H.R. 3433, the Grant Reform and New Transparency Act Hematology workforce issues
Preserving Access to Life-Saving Medications Act of 2011
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act H.R. 3839, the Drug Shortage Prevention Act Hematology workforce issues Clinical Trials
Thrombosis Sickle Cell Disease/Trait Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine H.R. 3433, the Grant Reform and New Transparency Act
Thrombosis Sickle Cell Disease/Trait Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine H.R. 3433, the Grant Reform and New Transparency Act
Thrombosis Sickle Cell Disease/Trait Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act H.R. 3839, the Drug Shortage Prevention Act H.R. 3433, the Grant Reform and New Transparency Act Hematology workforce issues
Drug Shortage Prevention Act of 2012
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Thrombosis Sickle Cell Disease/Trait Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act H.R. 3839, the Drug Shortage Prevention Act H.R. 3433, the Grant Reform and New Transparency Act Hematology workforce issues
Drug Shortage Prevention Act of 2012
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act H.R. 3839, the Drug Shortage Prevention Act Hematology workforce issues Clinical Trials
American Taxpayer Relief Act of 2012
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2013 Funding for the National Institutes of Health Public Health Program Funding S. 3295, Department of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2013 H.R. 8, American Taxpayer Relief Act of 2012
Preserving Access to Life-Saving Medications Act of 2011
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Thrombosis Sickle Cell Disease Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues H.R. 2376, the Stem Cell Research Advancement Act of 2011 S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act H.R. 640, the Bone Marrow Failure Disease Research and Treatment Act S.Res. 172, resolution designating May 2011 as National Cancer Research Month
Preserving Access to Life-Saving Medications Act of 2011
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Thrombosis Sickle Cell Disease Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues H.R. 2376, the Stem Cell Research Advancement Act of 2011 S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act Hematology workforce issues
Preserving Access to Life-Saving Medications Act of 2011
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Thrombosis Sickle Cell Disease Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues H.R. 2376, the Stem Cell Research Advancement Act of 2011 S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act Hematology workforce issues
Stem Cell Research Advancement Act of 2011
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Thrombosis Sickle Cell Disease Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues H.R. 2376, the Stem Cell Research Advancement Act of 2011 S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act H.R. 640, the Bone Marrow Failure Disease Research and Treatment Act S.Res. 172, resolution designating May 2011 as National Cancer Research Month
Stem Cell Research Advancement Act of 2011
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Thrombosis Sickle Cell Disease Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues H.R. 2376, the Stem Cell Research Advancement Act of 2011 S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act Hematology workforce issues
Stem Cell Research Advancement Act of 2011
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Thrombosis Sickle Cell Disease Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues H.R. 2376, the Stem Cell Research Advancement Act of 2011 S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act Hematology workforce issues
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2012 Funding for the National Institutes of Health Public Health Program Funding Budget Control Act of 2011 (S. 365) Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012 (S. 1599/H.R. 3070)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2012 Funding for the National Institutes of Health Public Health Program Funding Budget Control Act of 2011 (S. 365) Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012 (S. 1599/H.R. 3070) Consolidated Appropriations Act, 2012 (H.R. 3671)
Consolidated Appropriations Act, 2012
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2012 Funding for the National Institutes of Health Public Health Program Funding Budget Control Act of 2011 (S. 365) Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012 (S. 1599/H.R. 3070) Consolidated Appropriations Act, 2012 (H.R. 3671)
Bone Marrow Failure Disease Research and Treatment Act of 2011
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Thrombosis Sickle Cell Disease Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues H.R. 2376, the Stem Cell Research Advancement Act of 2011 S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act H.R. 640, the Bone Marrow Failure Disease Research and Treatment Act S.Res. 172, resolution designating May 2011 as National Cancer Research Month
Bone Marrow Failure Disease Research and Treatment Act of 2011
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
H.R. 640, the Bone Marrow Failure Disease Research and Treatment Act General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues Embryonic Stem Cell Research and Regenerative Medicine Sickle Cell Disease Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Comparative Effectiveness Research S. 296, the Preserving Access to Life-Saving Medications Act
Acquired Bone Marrow Failure Disease Research and Treatment Act of 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Clinical Trials Insurance Coverage Resolution Expressing Support for Designation of September 2010 as Blood Cancer Awareness Month (H.Res. 1433) Comparative Effectiveness Research Proposed Revisions to NIH COI Policy Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081)
Acquired Bone Marrow Failure Disease Research and Treatment Act of 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Advancement Act (H.R. 4808) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology Treatment Issues Clinical Trials Insurance Coverage
Acquired Bone Marrow Failure Disease Research and Treatment Act of 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Advancement Act (H.R. 4808) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Resolution Expressing Support for Designation of September 2010 as Blood Cancer Awareness Month (H.Res. 1433) Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology treatment Issues Clinical Trials Insurance Coverage Electronic Prescription for Controlled Substances
Acquired Bone Marrow Failure Disease Research and Treatment Act of 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Comparative Effectiveness Research Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081) Use of Cesium-137 Chloride (CsCl) sources in biomedical research
America's Affordable Health Choices Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590)
America's Affordable Health Choices Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment; Medicare Reimbursement; Medicare Coverage Policies Medicare Physician Payment Reform Act of 2009 (H.R. 3961) / Medicare Physician Fairness Act (S. 1776) /Continuing Extension Act of 2010 (H.R. 4851) Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590)
An Act to extend expiring provisions of the USA PATRIOT Improvement and Reauthorization Act of 2005 and Intelligence Reform and Terrorism Prevention Act of 2004 until February 28, 2011.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment; Medicare Reimbursement; Medicare Coverage Policies Medicare Physician Payment Reform Act of 2009 (H.R. 3961) / Medicare Physician Fairness Act (S. 1776) /Continuing Extension Act of 2010 (H.R. 4851) Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590)
Stem Cell Research Advancement Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Advancement Act (H.R. 4808) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology Treatment Issues Clinical Trials Insurance Coverage
Stem Cell Research Advancement Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Clinical Trials Insurance Coverage Resolution Expressing Support for Designation of September 2010 as Blood Cancer Awareness Month (H.Res. 1433) Comparative Effectiveness Research Proposed Revisions to NIH COI Policy Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081)
Stem Cell Research Advancement Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Comparative Effectiveness Research Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081) Use of Cesium-137 Chloride (CsCl) sources in biomedical research
Stem Cell Research Advancement Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Advancement Act (H.R. 4808) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Resolution Expressing Support for Designation of September 2010 as Blood Cancer Awareness Month (H.Res. 1433) Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology treatment Issues Clinical Trials Insurance Coverage Electronic Prescription for Controlled Substances
Continuing Extension Act of 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment; Medicare Reimbursement; Medicare Coverage Policies Medicare Physician Payment Reform Act of 2009 (H.R. 3961) / Medicare Physician Fairness Act (S. 1776) /Continuing Extension Act of 2010 (H.R. 4851) Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590)
Continuing Extension Act of 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Continuing Extension Act of 2010 (H.R. 4851) / American Jobs and Closing Tax Loopholes Act of 2010 (H.R. 4213) / PAID FOR Temporary Extension Act of 2010 (S. 3421) / Preservation of Access to Care for Medicare Beneficaries and Pension Relief Act of 2010 (H.R. 3962) Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (H.R. 3590 / P.L. 111-148)
Medicare and Medicaid Extenders Act of 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Medicare and Medicaid Extenders Act of 2010 (H.R. 4994) Physician Payment and Therapy Relief Act of 2010 (H.R. 5712) Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Physician Quality Reporting Initiative (PQRS) Measures Electronic Health Records CMS Strategic Priorities
Physician Payment and Therapy Relief Act of 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Medicare and Medicaid Extenders Act of 2010 (H.R. 4994) Physician Payment and Therapy Relief Act of 2010 (H.R. 5712) Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Physician Quality Reporting Initiative (PQRS) Measures Electronic Health Records CMS Strategic Priorities
Stem Cell Therapeutic and Research Reauthorization Act of 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Clinical Trials Insurance Coverage Resolution Expressing Support for Designation of September 2010 as Blood Cancer Awareness Month (H.Res. 1433) Comparative Effectiveness Research Proposed Revisions to NIH COI Policy Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081)
Stem Cell Therapeutic and Research Reauthorization Act of 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Comparative Effectiveness Research Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081) Use of Cesium-137 Chloride (CsCl) sources in biomedical research
Expressing support for designation of September 2010 as Blood Cancer Awareness Month.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Clinical Trials Insurance Coverage Resolution Expressing Support for Designation of September 2010 as Blood Cancer Awareness Month (H.Res. 1433) Comparative Effectiveness Research Proposed Revisions to NIH COI Policy Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081)
Expressing support for designation of September 2010 as Blood Cancer Awareness Month.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Advancement Act (H.R. 4808) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Resolution Expressing Support for Designation of September 2010 as Blood Cancer Awareness Month (H.Res. 1433) Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology treatment Issues Clinical Trials Insurance Coverage Electronic Prescription for Controlled Substances
Medicare Physician Fairness Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment; Medicare Reimbursement; Medicare Coverage Policies Medicare Physician Payment Reform Act of 2009 (H.R. 3961) / Medicare Physician Fairness Act (S. 1776) /Continuing Extension Act of 2010 (H.R. 4851) Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590)
Protecting Against Indebting our Descendants through Fully Offset Relief (PAID FOR) Temporary Extension Act of 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Continuing Extension Act of 2010 (H.R. 4851) / American Jobs and Closing Tax Loopholes Act of 2010 (H.R. 4213) / PAID FOR Temporary Extension Act of 2010 (S. 3421) / Preservation of Access to Care for Medicare Beneficaries and Pension Relief Act of 2010 (H.R. 3962) Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (H.R. 3590 / P.L. 111-148)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Funding for the National Institutes of Health Public Health Program Funding House and Senate (S. 3686) FY 2011 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Bills
Stem Cell Therapeutic and Research Reauthorization Act of 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Clinical Trials Insurance Coverage Resolution Expressing Support for Designation of September 2010 as Blood Cancer Awareness Month (H.Res. 1433) Comparative Effectiveness Research Proposed Revisions to NIH COI Policy Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081)
Stem Cell Therapeutic and Research Reauthorization Act of 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Comparative Effectiveness Research Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081) Use of Cesium-137 Chloride (CsCl) sources in biomedical research
Stem Cell Research Advancement Act of 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Comparative Effectiveness Research Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081) Use of Cesium-137 Chloride (CsCl) sources in biomedical research
Stem Cell Research Advancement Act of 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Clinical Trials Insurance Coverage Resolution Expressing Support for Designation of September 2010 as Blood Cancer Awareness Month (H.Res. 1433) Comparative Effectiveness Research Proposed Revisions to NIH COI Policy Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081)
Montgomery GI Bill Degree Extension Act of 2007
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Continuing Appropriations and Surface Transportation Extensions Act, 2011 (H.R. 3082) Funding for the National Institutes of Health Public Health Program Funding House and Senate FY 2011 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Bills
American Middle Class Tax (AMT) Relief Act of 2007
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590)
American Middle Class Tax (AMT) Relief Act of 2007
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation / Patient Protection and Afforadable Care Act (H.R. 3590 / P.L. 111-148)
American Middle Class Tax (AMT) Relief Act of 2007
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment; Medicare Reimbursement; Medicare Coverage Policies Medicare Physician Payment Reform Act of 2009 (H.R. 3961) / Medicare Physician Fairness Act (S. 1776) /Continuing Extension Act of 2010 (H.R. 4851) Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590)
American Middle Class Tax (AMT) Relief Act of 2007
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Continuing Extension Act of 2010 (H.R. 4851) / American Jobs and Closing Tax Loopholes Act of 2010 (H.R. 4213) / PAID FOR Temporary Extension Act of 2010 (S. 3421) / Preservation of Access to Care for Medicare Beneficaries and Pension Relief Act of 2010 (H.R. 3962) Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (H.R. 3590 / P.L. 111-148)
Superfund Polluter Pays Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment; Medicare Reimbursement; Medicare Coverage Policies Medicare Physician Payment Reform Act of 2009 (H.R. 3961) / Medicare Physician Fairness Act (S. 1776) /Continuing Extension Act of 2010 (H.R. 4851) Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590)
Superfund Polluter Pays Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590)
Acquired Bone Marrow Failure Disease Research and Treatment Act of 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R. 873/S. 487), Somatic Cell Nuclear Transfer, Human Reproductive Cloning Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act (S. 717) Physician Payments Sunshine Act (S. 301) General Hematology-Related Research Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources and Radioisotopes in Biomedical Research
Acquired Bone Marrow Failure Disease Research and Treatment Act of 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R.873/S.487) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R.1230) Health Reform Legislation/ America's Affordable Health Choices Act of 2009 (H.R.3200) /Affordable Health Choices Act (S.1679) Physician Payments Sunshine Act (S.301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources in Biomedical Research
Acquired Bone Marrow Failure Disease Research and Treatment Act of 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R. 873/S. 487); Embryonic Stem Cell Research; Somatic Cell Nuclear Transfer; Human Reproductive Cloning Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) 21st Century Cancer ALERT Act (S. 717) Physician Payments Sunshine Act (S. 301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources in Biomedical Research Health Reform Legislation
Acquired Bone Marrow Failure Disease Research and Treatment Act of 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R. 873/S. 487) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590) Physician Payments Sunshine Act (S. 301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology Treatment Issues Clinical Trials Insurance Coverage
America's Affordable Health Choices Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment; Medicare Reimbursement; Medicare Coverage Policies Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Health Reform Legislation/ America's Affordable Health Choices Act of 2009 (H.R.3200) /Affordable Health Choices Act (S.1679)
America's Affordable Health Choices Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment; Medicare Reimbursement; Medicare Coverage Policies Medicare Physician Payment Reform Act of 2009 (H.R. 3961) / Medicare Physician Fairness Act (S. 1776) Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590)
America's Affordable Health Choices Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R. 873/S. 487) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590) Physician Payments Sunshine Act (S. 301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology Treatment Issues Clinical Trials Insurance Coverage
America's Affordable Health Choices Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R.873/S.487) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R.1230) Health Reform Legislation/ America's Affordable Health Choices Act of 2009 (H.R.3200) /Affordable Health Choices Act (S.1679) Physician Payments Sunshine Act (S.301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources in Biomedical Research
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Funding for the National Institutes of Health House and Senate FY 2010 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Bills (H.R.3293) Public Health Program Funding House and Senate FY 2010 Department of Defense Appropriations Bill (H.R.3326)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Funding for the National Institutes of Health House and Senate FY 2010 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Bills (H.R.3293) Public Health Program Funding House and Senate FY 2010 Department of Defense Appropriations Bill (H.R.3326)
An Act to extend expiring provisions of the USA PATRIOT Improvement and Reauthorization Act of 2005 and Intelligence Reform and Terrorism Prevention Act of 2004 until February 28, 2011.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment; Medicare Reimbursement; Medicare Coverage Policies Medicare Physician Payment Reform Act of 2009 (H.R. 3961) / Medicare Physician Fairness Act (S. 1776) Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590)
Stem Cell Research Enhancement Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R. 873/S. 487) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590) Physician Payments Sunshine Act (S. 301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology Treatment Issues Clinical Trials Insurance Coverage
Stem Cell Research Enhancement Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R.873/S.487) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R.1230) Health Reform Legislation/ America's Affordable Health Choices Act of 2009 (H.R.3200) /Affordable Health Choices Act (S.1679) Physician Payments Sunshine Act (S.301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources in Biomedical Research
Stem Cell Research Enhancement Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R. 873/S. 487); Embryonic Stem Cell Research; Somatic Cell Nuclear Transfer; Human Reproductive Cloning Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) 21st Century Cancer ALERT Act (S. 717) Physician Payments Sunshine Act (S. 301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources in Biomedical Research Health Reform Legislation
Stem Cell Research Enhancement Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R. 873/S. 487), Somatic Cell Nuclear Transfer, Human Reproductive Cloning Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act (S. 717) Physician Payments Sunshine Act (S. 301) General Hematology-Related Research Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources and Radioisotopes in Biomedical Research
Affordable Health Choices Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R.873/S.487) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R.1230) Health Reform Legislation/ America's Affordable Health Choices Act of 2009 (H.R.3200) /Affordable Health Choices Act (S.1679) Physician Payments Sunshine Act (S.301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources in Biomedical Research
Affordable Health Choices Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment; Medicare Reimbursement; Medicare Coverage Policies Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Health Reform Legislation/ America's Affordable Health Choices Act of 2009 (H.R.3200) /Affordable Health Choices Act (S.1679)
Medicare Physician Fairness Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment; Medicare Reimbursement; Medicare Coverage Policies Medicare Physician Payment Reform Act of 2009 (H.R. 3961) / Medicare Physician Fairness Act (S. 1776) Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590)
Physician Payments Sunshine Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R. 873/S. 487); Embryonic Stem Cell Research; Somatic Cell Nuclear Transfer; Human Reproductive Cloning Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) 21st Century Cancer ALERT Act (S. 717) Physician Payments Sunshine Act (S. 301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources in Biomedical Research Health Reform Legislation
Physician Payments Sunshine Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R. 873/S. 487) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590) Physician Payments Sunshine Act (S. 301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology Treatment Issues Clinical Trials Insurance Coverage
Physician Payments Sunshine Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R. 873/S. 487), Somatic Cell Nuclear Transfer, Human Reproductive Cloning Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act (S. 717) Physician Payments Sunshine Act (S. 301) General Hematology-Related Research Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources and Radioisotopes in Biomedical Research
Physician Payments Sunshine Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R.873/S.487) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R.1230) Health Reform Legislation/ America's Affordable Health Choices Act of 2009 (H.R.3200) /Affordable Health Choices Act (S.1679) Physician Payments Sunshine Act (S.301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources in Biomedical Research
Stem Cell Research Enhancement Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R. 873/S. 487), Somatic Cell Nuclear Transfer, Human Reproductive Cloning Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act (S. 717) Physician Payments Sunshine Act (S. 301) General Hematology-Related Research Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources and Radioisotopes in Biomedical Research
Stem Cell Research Enhancement Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R. 873/S. 487) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590) Physician Payments Sunshine Act (S. 301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology Treatment Issues Clinical Trials Insurance Coverage
Stem Cell Research Enhancement Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R. 873/S. 487); Embryonic Stem Cell Research; Somatic Cell Nuclear Transfer; Human Reproductive Cloning Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) 21st Century Cancer ALERT Act (S. 717) Physician Payments Sunshine Act (S. 301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources in Biomedical Research Health Reform Legislation
Stem Cell Research Enhancement Act of 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R.873/S.487) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R.1230) Health Reform Legislation/ America's Affordable Health Choices Act of 2009 (H.R.3200) /Affordable Health Choices Act (S.1679) Physician Payments Sunshine Act (S.301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources in Biomedical Research
21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R. 873/S. 487); Embryonic Stem Cell Research; Somatic Cell Nuclear Transfer; Human Reproductive Cloning Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) 21st Century Cancer ALERT Act (S. 717) Physician Payments Sunshine Act (S. 301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources in Biomedical Research Health Reform Legislation
21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R. 873/S. 487), Somatic Cell Nuclear Transfer, Human Reproductive Cloning Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act (S. 717) Physician Payments Sunshine Act (S. 301) General Hematology-Related Research Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources and Radioisotopes in Biomedical Research
American Middle Class Tax (AMT) Relief Act of 2007
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R. 873/S. 487) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590) Physician Payments Sunshine Act (S. 301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology Treatment Issues Clinical Trials Insurance Coverage
American Middle Class Tax (AMT) Relief Act of 2007
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment; Medicare Reimbursement; Medicare Coverage Policies Medicare Physician Payment Reform Act of 2009 (H.R. 3961) / Medicare Physician Fairness Act (S. 1776) Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590)
Superfund Polluter Pays Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment; Medicare Reimbursement; Medicare Coverage Policies Medicare Physician Payment Reform Act of 2009 (H.R. 3961) / Medicare Physician Fairness Act (S. 1776) Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590)
Superfund Polluter Pays Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Stem Cell Research Enhancement Act (H.R. 873/S. 487) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590) Physician Payments Sunshine Act (S. 301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology Treatment Issues Clinical Trials Insurance Coverage
Stem Cell Research Enhancement Act of 2007
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Coverage/Labeling of Erythropoiesis-Stimulating Agents (ESAs) Stem Cell Research Enhancement Act (H.R. 3/S. 5), Somatic Cell Nuclear Transfer, Human Reproductive Cloning Genetic Information Nondiscrimination Act (S. 358/H.R. 493) General Hematology-Related Research Sickle Cell Disease Public Access
Stem Cell Research Enhancement Act of 2007
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Coverage/Labeling of Erythropoiesis-Stimulating Agents (ESAs) Stem Cell Research Enhancement Act (H.R. 3/S. 5), Somatic Cell Nuclear Transfer, Human Reproductive Cloning General Hematology-Related Research Sickle Cell Disease Public Access Thrombosis Security and Continued Use of Cesium-137 Chloride Sources in Biomedical Research
Stem Cell Research Enhancement Act of 2007
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Coverage/Labeling of Erythropoiesis-Stimulating Agents (ESAs) Stem Cell Research Enhancement Act (H.R. 3/S. 5), Somatic Cell Nuclear Transfer, Human Reproductive Cloning Genetic Information Nondiscrimination Act (S. 358/H.R. 493) General Hematology-Related Research Sickle Cell Disease Public Access Thrombosis Security and Continued Use of Cesium-137 Chloride Sources in Biomedical Research
Stem Cell Research Enhancement Act of 2007
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Coverage/Labeling of Erythropoiesis-Stimulating Agents (ESAs) Stem Cell Research Enhancement Act (H.R. 3/S. 5), Somatic Cell Nuclear Transfer, Human Reproductive Cloning Genetic Information Nondiscrimination Act (S. 358/H.R. 493) General Hematology-Related Research Sickle Cell Disease Public Access Thrombosis
Medicare Improvements for Patients and Providers Act of 2008
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment Medicare Reimbursement Hospital Outpatient APCs Save Medicare Act of 2008 (S. 2785) Medicare Improvements for Patients and Providers Act (H.R. 6331/S. 3101) Potential National Coverage Decision Topics Proposed Rule on the Electronic Prescriptions for Controlled Substances
Medicare Improvements for Patients and Providers Act of 2008
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Coverage of Erythropoiesis-Stimulating Agents (ESAs) Medicare Physician Payment Medicare Reimbursement Hospital Outpatient APCs Save Medicare Act of 2008 (S. 2785) Medicare Improvements for Patients and Providers Act (H.R. 6331/S. 3101)
Save Medicare Act of 2008
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment Medicare Reimbursement Hospital Outpatient APCs Save Medicare Act of 2008 (S. 2785) Medicare Improvements for Patients and Providers Act (H.R. 6331/S. 3101) Potential National Coverage Decision Topics Proposed Rule on the Electronic Prescriptions for Controlled Substances
Save Medicare Act of 2008
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Coverage of Erythropoiesis-Stimulating Agents (ESAs) Medicare Physician Payment Medicare Reimbursement Hospital Outpatient APCs Save Medicare Act of 2008 (S. 2785) Medicare Improvements for Patients and Providers Act (H.R. 6331/S. 3101)
Medicare Improvements for Patients and Providers Act of 2008
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Coverage of Erythropoiesis-Stimulating Agents (ESAs) Medicare Physician Payment Medicare Reimbursement Hospital Outpatient APCs Save Medicare Act of 2008 (S. 2785) Medicare Improvements for Patients and Providers Act (H.R. 6331/S. 3101)
Medicare Improvements for Patients and Providers Act of 2008
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Physician Payment Medicare Reimbursement Hospital Outpatient APCs Save Medicare Act of 2008 (S. 2785) Medicare Improvements for Patients and Providers Act (H.R. 6331/S. 3101) Potential National Coverage Decision Topics Proposed Rule on the Electronic Prescriptions for Controlled Substances
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2009 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act (S. 3230) Funding for the National Institutes of Health Public Health Program Funding FY 2009 Department of Defense Appropriations Act FY 2008 Supplemental Appropriations Act (H.R. 2642) FY 2009 Continuing Resolution (H.R. 2638)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2009 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act (S. 3230) Funding for the National Institutes of Health Public Health Program Funding FY 2009 Department of Defense Appropriations Act FY 2008 Supplemental Appropriations Act (H.R. 2642) FY 2009 Continuing Resolution (H.R. 2638) Job Creation and Unemployment Relief Act of 2008 (S. 3688, S. 3689)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2009
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2009 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act (S. 3230) Funding for the National Institutes of Health Public Health Program Funding FY 2009 Department of Defense Appropriations Act FY 2008 Supplemental Appropriations Act (H.R. 2642)
Genetic Information Nondiscrimination Act of 2007
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Coverage/Labeling of Erythropoiesis-Stimulating Agents (ESAs) Stem Cell Research Enhancement Act (H.R. 3/S. 5), Somatic Cell Nuclear Transfer, Human Reproductive Cloning Genetic Information Nondiscrimination Act (S. 358/H.R. 493) General Hematology-Related Research Sickle Cell Disease Public Access
FY 2014 Funding for the National Institutes of Health Public Health Program Funding
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2013 · first_quarter · Q1
FY 2013 Funding for the National Institutes of Health Public Health Program Funding H.R. 933, Consolidated and Further Continuing Appropriations Act, 2013 H.R. 8, American Taxpayer Relief Act of 2012
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials regulations and coverage
Sickle Cell Disease/Trait Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2012 · fourth_quarter · Q4
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials regulations and coverage
FY 2013 Funding for the National Institutes of Health Public Health Program Funding S. 3295, Department of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2013 H.R. 8, American Taxpayer Relief Act of 2012
Sickle Cell Disease/Trait Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2012 · third_quarter · Q3
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Physician Quality Reporting System (PQRS) Measures CMS Strategic Priorities Clinical Trials Regulations Electronic Health Records (EHR)
Thrombosis Sickle Cell Disease/Trait Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine H.R. 3433, the Grant Reform and New Transparency Act
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Hematology workforce issues The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials regulations and coverage
FY 2013 Funding for the National Institutes of Health Public Health Program Funding S. 3295, Department of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2013
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2012 · second_quarter · Q2
FY 2013 Funding for the National Institutes of Health Public Health Program Funding
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act H.R. 3839, the Drug Shortage Prevention Act Hematology workforce issues Clinical Trials
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Physician Quality Reporting System (PQRS) Measures CMS Strategic Priorities Clinical Trials Regulations Electronic Health Records (EHR)
Thrombosis Sickle Cell Disease/Trait Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine H.R. 3433, the Grant Reform and New Transparency Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2012 · first_quarter · Q1
Thrombosis Sickle Cell Disease/Trait Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act H.R. 3839, the Drug Shortage Prevention Act H.R. 3433, the Grant Reform and New Transparency Act Hematology workforce issues
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies (H.R. 3630, the Middle Class Tax Relief and Job creation Act of 2012) Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Physician Quality Reporting System (PQRS) Measures Electronic Health Records CMS Strategic Priorities
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2011 · fourth_quarter · Q4
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Physician Quality Reporting System (PQRS) Measures Electronic Health Records CMS Strategic Priorities
FY 2012 Funding for the National Institutes of Health Public Health Program Funding Budget Control Act of 2011 (S. 365) Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012 (S. 1599/H.R. 3070) Consolidated Appropriations Act, 2012 (H.R. 3671)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2011 · third_quarter · Q3
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Physician Quality Reporting System (PQRS) Measures Electronic Health Records CMS Strategic Priorities
FY 2012 Funding for the National Institutes of Health Public Health Program Funding Budget Control Act of 2011 (S. 365) Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2012 (S. 1599/H.R. 3070)
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Health Insurance Portability and Accountability Act
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2011 · second_quarter · Q2
Thrombosis Sickle Cell Disease Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues H.R. 2376, the Stem Cell Research Advancement Act of 2011 S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act H.R. 640, the Bone Marrow Failure Disease Research and Treatment Act S.Res. 172, resolution designating May 2011 as National Cancer Research Month
FY 2011 and FY 2012 Funding for the National Institutes of Health Public Health Program Funding H.R. 1473, Department of Defense and Full-Year Continuing Appropriations Act, 2011
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2011 · first_quarter · Q1
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Health Insurance Portability and Accountability Act
H.R. 640, the Bone Marrow Failure Disease Research and Treatment Act General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues Embryonic Stem Cell Research and Regenerative Medicine Sickle Cell Disease Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Comparative Effectiveness Research S. 296, the Preserving Access to Life-Saving Medications Act
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2010 · fourth_quarter · Q4
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Medicare and Medicaid Extenders Act of 2010 (H.R. 4994) Physician Payment and Therapy Relief Act of 2010 (H.R. 5712) Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Physician Quality Reporting Initiative (PQRS) Measures Electronic Health Records CMS Strategic Priorities
Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Comparative Effectiveness Research Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081) Use of Cesium-137 Chloride (CsCl) sources in biomedical research
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2010 · third_quarter · Q3
Funding for the National Institutes of Health Public Health Program Funding House and Senate (S. 3686) FY 2011 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Bills
Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Clinical Trials Insurance Coverage Resolution Expressing Support for Designation of September 2010 as Blood Cancer Awareness Month (H.Res. 1433) Comparative Effectiveness Research Proposed Revisions to NIH COI Policy Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2010 · second_quarter · Q2
Implementation of Health Reform Legislation / Patient Protection and Afforadable Care Act (H.R. 3590 / P.L. 111-148)
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Continuing Extension Act of 2010 (H.R. 4851) / American Jobs and Closing Tax Loopholes Act of 2010 (H.R. 4213) / PAID FOR Temporary Extension Act of 2010 (S. 3421) / Preservation of Access to Care for Medicare Beneficaries and Pension Relief Act of 2010 (H.R. 3962) Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (H.R. 3590 / P.L. 111-148)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2010 · first_quarter · Q1
Medicare Physician Payment; Medicare Reimbursement; Medicare Coverage Policies Medicare Physician Payment Reform Act of 2009 (H.R. 3961) / Medicare Physician Fairness Act (S. 1776) /Continuing Extension Act of 2010 (H.R. 4851) Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590)
Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2009 · fourth_quarter · Q4
Medicare Physician Payment; Medicare Reimbursement; Medicare Coverage Policies Medicare Physician Payment Reform Act of 2009 (H.R. 3961) / Medicare Physician Fairness Act (S. 1776) Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590)
Funding for the National Institutes of Health House and Senate FY 2010 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Bills (H.R.3293) Public Health Program Funding House and Senate FY 2010 Department of Defense Appropriations Bill (H.R.3326)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2009 · third_quarter · Q3
Funding for the National Institutes of Health House and Senate FY 2010 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Bills (H.R.3293) Public Health Program Funding House and Senate FY 2010 Department of Defense Appropriations Bill (H.R.3326)
Medicare Physician Payment; Medicare Reimbursement; Medicare Coverage Policies Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Health Reform Legislation/ America's Affordable Health Choices Act of 2009 (H.R.3200) /Affordable Health Choices Act (S.1679)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2009 · second_quarter · Q2
Medicare Physician Payment; Medicare Reimbursement; Medicare Coverage Policies Physician Quality Reporting Initiative (PQRI) Measures Electronic Health Records (EHRs) Health Reform Legislation
Funding for the National Institutes of Health FY 2010 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Bills Public Health Program Funding FY 2010 Department of Defense Appropriations bill
Stem Cell Research Enhancement Act (H.R. 873/S. 487); Embryonic Stem Cell Research; Somatic Cell Nuclear Transfer; Human Reproductive Cloning Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) 21st Century Cancer ALERT Act (S. 717) Physician Payments Sunshine Act (S. 301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources in Biomedical Research Health Reform Legislation
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2009 · first_quarter · Q1
Medicare Physician Payment Medicare Reimbursement Potential National Coverage Decision Topics Physician Quality Reporting Initiative (PQRI) measures
Funding for the National Institutes of Health American Recovery and Reinvestment Act of 2009 (H.R. 1) FY 2009 Omnibus Appropriations Act (H.R. 1105) FY 2010 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act Public Health Program Funding FY 2010 Department of Defense Appropriations Act
Stem Cell Research Enhancement Act (H.R. 873/S. 487), Somatic Cell Nuclear Transfer, Human Reproductive Cloning Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) 21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act (S. 717) Physician Payments Sunshine Act (S. 301) General Hematology-Related Research Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources and Radioisotopes in Biomedical Research
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2008 · fourth_quarter · Q4
FY 2009 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act (S. 3230) Funding for the National Institutes of Health Public Health Program Funding FY 2009 Department of Defense Appropriations Act FY 2008 Supplemental Appropriations Act (H.R. 2642) FY 2009 Continuing Resolution (H.R. 2638) Job Creation and Unemployment Relief Act of 2008 (S. 3688, S. 3689)
Coverage/Labeling of Erythropoiesis-Stimulating Agents (ESAs) Stem Cell Research Enhancement Act (H.R. 3/S. 5), Somatic Cell Nuclear Transfer, Human Reproductive Cloning General Hematology-Related Research Sickle Cell Disease Public Access Thrombosis Security and Continued Use of Cesium-137 Chloride Sources in Biomedical Research
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2008 · third_quarter · Q3
Coverage/Labeling of Erythropoiesis-Stimulating Agents (ESAs) Stem Cell Research Enhancement Act (H.R. 3/S. 5), Somatic Cell Nuclear Transfer, Human Reproductive Cloning Genetic Information Nondiscrimination Act (S. 358/H.R. 493) General Hematology-Related Research Sickle Cell Disease Public Access Thrombosis Security and Continued Use of Cesium-137 Chloride Sources in Biomedical Research
FY 2009 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act (S. 3230) Funding for the National Institutes of Health Public Health Program Funding FY 2009 Department of Defense Appropriations Act FY 2008 Supplemental Appropriations Act (H.R. 2642) FY 2009 Continuing Resolution (H.R. 2638)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2008 · second_quarter · Q2
Coverage/Labeling of Erythropoiesis-Stimulating Agents (ESAs) Stem Cell Research Enhancement Act (H.R. 3/S. 5), Somatic Cell Nuclear Transfer, Human Reproductive Cloning Genetic Information Nondiscrimination Act (S. 358/H.R. 493) General Hematology-Related Research Sickle Cell Disease Public Access Thrombosis
FY 2009 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act (S. 3230) Funding for the National Institutes of Health Public Health Program Funding FY 2009 Department of Defense Appropriations Act FY 2008 Supplemental Appropriations Act (H.R. 2642)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2008 · first_quarter · Q1
Medicare Coverage of Erythropoiesis-Stimulating Agents (ESAs) Medicare Physician Payments Medicare Reimbursement Hospital Outpatient APCs
FY 2009 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act Funding for the National Institutes of Health Public Health Program Funding
Coverage/Labeling of Erythropoiesis-Stimulating Agents (ESAs) Stem Cell Research Enhancement Act (H.R. 3/S. 5), Somatic Cell Nuclear Transfer, Human Reproductive Cloning Genetic Information Nondiscrimination Act (S. 358/H.R. 493) General Hematology-Related Research Sickle Cell Disease Public Access
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2007 · year_end · YY
H.R. 3043/S. 1710, FY 2008 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act Funding for the National Institutes of Health Public Health Program Funding
Medicare Coverage of Erythropoiesis-Stimulating Agents (ESAs) Medicare Physician Payments Medicare Reimbursement Hospital Outpatient APCs
Coverage/Labeling of Erythropoiesis-Stimulating Agents (ESAs) H.R. 3/S. 5, Stem Cell Research Enhancement Act Somatic Cell Nuclear Transfer Human Reproductive Cloning
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2007 · mid_year · MM
Hospital Outpatient APCs Medicare Physician Payments Current Procedural Terminology (CPT) Codes Medicare Reimbursement
H.R. 3043/S. 1710, FY 2008 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act Funding for the National Institutes of Health Public Health Program Funding
S. 358/H.R. 493, Genetic Information Nondiscrimination Act (GINA) Public Access H.R. 3/S. 5, Stem Cell Research Enhancement Act Somatic Cell Nuclear Transfer Human Reproductive Cloning Sickle Cell Disease
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2006 · year_end · YY
* Medicare Prescription Drug Improvement and Modernization Act (MMA) of 2003 Hospital Outpatient APCs Medicare Physician Payments Current Procedural Terminology (CPT) Codes Medicare Reimbursement H.R. 5647/S. 3708, Departments of Labor, Health & Human Services, and Education, and Related Agencies Appropriations Act Funding for the National Institutes of Health Public Health Program Funding 2
S. 306/H.R. 1227, Genetic Information Nondiscrimination Act (GINA) H.R. 6164, National Institutes of Health Reform Act of 2006 Public Access H.R. 810, Stem Cell Research Enhancement Act Somatic Cell Nuclear Transfer Human Reproductive Cloning Sickle Cell Disease
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2006 · mid_year · MM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2005 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2005 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2004 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, White House Office
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2003 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
FY 2013 Funding for the National Institutes of Health Public Health Program Funding
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Health Insurance Portability and Accountability Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
Thrombosis Sickle Cell Disease Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues H.R. 2376, the Stem Cell Research Advancement Act of 2011 S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act Hematology workforce issues
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Health Insurance Portability and Accountability Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
Thrombosis Sickle Cell Disease Clinical Trials Regulations Electronic Health Records (EHR) Comparative Effectiveness Research Hematology/Oncology treatment Issues General Hematology Public Health and Research Issues Embryonic Stem Cell Research and Regenerative Medicine Hematology and Oncology Drug Research and Approval Issues, Drug Shortage Issues H.R. 2376, the Stem Cell Research Advancement Act of 2011 S. 296, the Preserving Access to Life-Saving Medications Act H.R. 2245, the Preserving Access to Life-Saving Medications Act Hematology workforce issues
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Health Insurance Portability and Accountability Act
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Physician Quality Reporting System (PQRS) Measures Electronic Health Records CMS Strategic Priorities
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
FY 2011 and FY 2012 Funding for the National Institutes of Health Public Health Program Funding H.R. 1, the 2011 Full-Year Continuing Appropriations Act
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Medicare Advantage Coverage of Routine Costs for Clinical Trials Participants Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Physician Quality Reporting System (PQRS) Measures Electronic Health Records CMS Strategic Priorities
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Health Insurance and Portability Act
Continuing Appropriations and Surface Transportation Extensions Act, 2011 (H.R. 3082) Funding for the National Institutes of Health Public Health Program Funding House and Senate FY 2011 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Bills
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) Health Insurance and Portability Act
Medicare Physician Payment: Medicare Reimbursement; Medicare Coverage Policies Electronic Health Records Implementation of Health Reform Legislation / Patient Protection and Affordable Care Act (P.L. 111-148) CMS Strategic Priorities Physician Quality Reporting Initiative (PQRI) Measures
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Funding for the National Institutes of Health House and Senate FY 2011 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Bills Public Health Program Funding
Stem Cell Research Advancement Act (H.R. 4808) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Resolution Expressing Support for Designation of September 2010 as Blood Cancer Awareness Month (H.Res. 1433) Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology treatment Issues Clinical Trials Insurance Coverage Electronic Prescription for Controlled Substances
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Funding for the National Institutes of Health House and Senate FY 2011 Departments of Labor, HHS, and Education, and Related Agencies Appropriations Bills Public Health Program Funding
Stem Cell Research Advancement Act (H.R. 4808) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology Treatment Issues Clinical Trials Insurance Coverage
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE
Stem Cell Research Enhancement Act (H.R. 873/S. 487) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) Health Reform Legislation: America's Affordable Health Choices Act of 2009 (H.R. 3200) /Affordable Health Care for America Act (H.R. 3962) / Patient Protection and Affordable Care Act (H.R. 3590) Physician Payments Sunshine Act (S. 301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHRs) Hematology/Oncology Treatment Issues Clinical Trials Insurance Coverage
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), President of the U.S., SENATE
Stem Cell Research Enhancement Act (H.R.873/S.487) / Embryonic Stem Cell Research Bone Marrow Failure Disease Research and Treatment Act (H.R.1230) Health Reform Legislation/ America's Affordable Health Choices Act of 2009 (H.R.3200) /Affordable Health Choices Act (S.1679) Physician Payments Sunshine Act (S.301) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Comparative Effectiveness Research (CER) Sickle Cell Disease Public Access Thrombosis Use of Cesium-137 Chloride Sources in Biomedical Research
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
Medicare Physician Payment Medicare Reimbursement Hospital Outpatient APCs Potential National Coverage Decision Topics
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
Medicare Physician Payment Medicare Reimbursement Hospital Outpatient APCs Save Medicare Act of 2008 (S. 2785) Medicare Improvements for Patients and Providers Act (H.R. 6331/S. 3101) Potential National Coverage Decision Topics Proposed Rule on the Electronic Prescriptions for Controlled Substances
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
Medicare Coverage of Erythropoiesis-Stimulating Agents (ESAs) Medicare Physician Payment Medicare Reimbursement Hospital Outpatient APCs Save Medicare Act of 2008 (S. 2785) Medicare Improvements for Patients and Providers Act (H.R. 6331/S. 3101)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office